Authors: Genre, D Viens, P Gravis, G Bertucci, F Cowen, D Novakovitch, G Dermeche, S Chabannon, C Oziel-Taieb, S Camerlo, J Houvenaeghel, G Jacquemier, J Maraninchi, D

Citation: D. Genre et al., Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: A phase I-II study, ANTICANC R, 20(3B), 2000, pp. 2033-2040

Authors: Viret, F Blaise, D Bouabdallah, R Stoppa, AM Novakovitch, G Faucher, C Vey, N Camerlo, J Oziel-Taieb, S Ladaique, P Gastaut, JA Maraninchi, D Chabannon, C

Citation: F. Viret et al., Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement, HEM CELL TH, 41(1), 1999, pp. 5-11

Authors: Chabannon, C Blache, JL Sielleur, I Douville, J Faucher, C Gravis, G Arnoulet, C Oziel-Taieb, S Blaise, D Novakovitch, G Camerlo, J Chabbert, I Genre, D Appel, M Armstrong, D Maraninchi, D Viens, P

Citation: C. Chabannon et al., Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-dosesof cyclophosphamide, INT J ONCOL, 15(3), 1999, pp. 511-518

Authors: Gravis, G Pech-Gourgh, F Viens, P Alzieu, C Camerlo, J Oziel-Taieb, S Jausseran, M Maraninchi, D

Citation: G. Gravis et al., Phase II study of a combination of low-dose cisplatin with 13-cis-retinoicacid and interferon-alpha in patients with advanced head and neck squamouscell carcinoma, ANTI-CANC D, 10(4), 1999, pp. 369-374

Authors: Viens, P Jacquemier, J Bardou, VJ Bertucci, F Penault-Llorca, F Puig, B Gravis, G Oziel-Taieb, S Resbeut, M Houvenaeghel, G Camerlo, J Birbaum, D Hassoun, J Maraninchi, D

Citation: P. Viens et al., Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy, BREAST CANC, 54(3), 1999, pp. 205-212